Obesity Management Primary Care: Clinics in Office Practice Journal2009,Primary Care: Clinics in Office Practice Nathan F.BradfordMD Hyperlipidemia Hyperlipidemiais associated with obesity in children, in the pattern of increasedtriglyceridesand low-density lipoprotein and decreased HDL. The accumulation of...
(conditional to survival for 1 year),2the benefit of treating hyperlipidemia remains debatable. Nonetheless, management guidelines used for the nontransplant population are usually used. If tolerated, treatment before transplantation is continued but drug-drug interactions especially with CCB and CNI ...
Clinical trials demonstrate significant benefit from cholesterol management for patients with cardiovascular disease (CVD). National guidelines recommendin... P Mcbride,HG Schrott,MB Plane,... - 《Archives of Internal Medicine》 被引量: 591发表: 1998年 The Effect of Vitamin C Supplementation on Diab...
S10Management of Hyperlipidemia Induced by Primary Biliary Cholangitisdoi:10.14309/01.ajg.0000897548.54402.30Ange Ahoussougbemey MeleNortheast Georgia Medical Center, Gainesville, Florida, United States.Riaz MahmoodNortheast Georgia Medical Center, Gainesville, Florida, United States.Henry Ogbuagu...
Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman M, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D (2011) ESC/EAS guidelines for the management of dyslipidaemias The Task ...
developed and tested, which would undoubtedly and significantly improve patient compliance with the prescribed medication [80,81]. As per the TC management guidelines, the roles of lifestyle, niacin derivatives, and cholesteryl ester transfer protein inhibitors in the control of TC have been ...
Formulation development and evaluation of pravastatin-loaded nanogel for hyperlipidemia management. Gels. 2022;8(2):81. Article CAS PubMed PubMed Central Google Scholar Kawata S, Yamasaki E, Nagase T, Inui Y, Ito N, Matsuda Y, et al. Effect of pravastatin on survival in patients with ...
In accordance with Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults published in 2007, hyperlipidemia was defined as the presence of any one of the following four conditions: hypercholesterolemia (total cholesterol (TC; ≥ 6.22 mmol/L); hypertriglyceridemia (triglycerides...
The NCEP III guidelines emphasize the importance of including older patients in the management of lipid disorders. Older patients have the highest risk for CAD and the highest burden of atherosclerotic disease. Although clinical trials of cholesterol-lowering therapy have not specifically targeted older ...
1,2 Lipid management is a cornerstone for ASCVD risk reduction and for the secondary prevention of CVD.3 One of the hallmarks of managing patients receiving lipid-lowering therapy is to match ASCVD status or risk with appropriate statin intensity.3 However, many patients are still not treated ...